Texas 2011 - 82nd 1st C.S.

Texas Senate Bill SB17

Voted on by Senate
 
Out of House Committee
 
Voted on by House
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to creation of a study committee for the Interstate Health Care Compact.

Impact

The establishment of this advisory committee could have significant implications for state healthcare laws. If Texas decides to fully engage with the compact, it could lead to the suspension of various federal healthcare laws within the state, thereby allowing Texas to create customized regulations that align better with local needs and conditions. This shift may impact a wide range of healthcare matters, including insurance coverage, provider regulations, and patient care standards. The discussions around the potential implementation highlight a movement toward more localized control over healthcare, which advocates argue is necessary to address Texas's unique healthcare landscape.

Summary

Senate Bill 17 seeks to establish a Texas Health Care Compact Advisory Committee which is intended to evaluate and recommend how the state can effectively implement the Interstate Health Care Compact. This compact allows states to take over certain healthcare regulatory responsibilities from the federal government. By potentially suspending federal laws that conflict with state regulations, the bill aims to give Texas greater control over its healthcare policies and administration. The creation of this advisory committee is seen as a critical first step toward realizing the compact's benefits as it prepares to assess the state's readiness and infrastructure to take control over healthcare regulation.

Sentiment

The sentiment surrounding SB 17 appears to be mixed, with one faction viewing the bill as a necessary measure to afford Texas more authority in regulating its healthcare sector. Proponents argue that this could lead to more tailored healthcare policies that better serve the people of Texas. Conversely, opponents may express concern over the implications of relinquishing federal oversight, fearing that this could lead to less protection for patients and a fragmentation of healthcare standards. The division in sentiment underscores the broader debate on state versus federal control over healthcare matters.

Contention

A notable point of contention regarding SB 17 revolves around the potential risks associated with increased state control over healthcare regulation. Critics might argue that the bill could undermine the safeguards that federal laws provide, particularly concerning access to care and patient protections. Furthermore, there may be concerns about the effectiveness of a state-led regulatory system compared to established federal ones. This brings into question whether state lawmakers have the necessary expertise and resources to manage such a comprehensive transition, which could affect the quality and availability of healthcare services across Texas.

Companion Bills

TX HB32

Identical Relating to creation of a study committee for the Interstate Health Care Compact.

Similar Bills

US HR198

Providing for the expenses of certain committees of the House of Representatives in the One Hundred Nineteenth Congress.

NM HJM2

Combine Standing & Interim Committees

WI AR2

Establishing the assembly committee structure and names for the 2025-2026 legislative session.

MN HC1

A house concurrent resolution relating to the regent nomination joint committee.

IL HR0020

HOUSE RULES-AMEND

CA AB1350

Employment Development Department: policies and practices.

TX HB2229

Relating to the creation of the Texas HIV Medication Advisory Committee.

TX SB1821

Relating to the creation of the Texas HIV Medication Advisory Committee.